ABMD Share Price

Open 117.03 Change Price %
High 117.22 1 Day -0.11 -0.09
Low 114.36 1 Week 0.32 0.27
Close 116.89 1 Month 4.59 4.09
Volume 289257 1 Year 36.00 44.50
52 Week High 132.95
52 Week Low 79.62
ABMD Important Levels
Resistance 2 119.54
Resistance 1 118.45
Pivot 116.16
Support 1 115.33
Support 2 114.24
NASDAQ USA Most Active Stocks
NVDA 100.49 -9.27%
JBHT 97.31 -1.05%
AREX 2.96 -1.99%
OZRK 55.54 1.02%
FNSR 34.15 0.12%
AGNC 19.64 0.72%
EA 86.65 -0.84%
FNFG 10.18 -0.20%
PRFZ 118.04 -0.80%
DELL 13.86 0.22%
More..
NASDAQ USA Top Gainers Stocks
ECTE 0.18 50.00%
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
ZAZA 0.06 20.00%
JAKK 5.70 12.87%
LINE 0.18 12.50%
More..
NASDAQ USA Top Losers Stocks
DEER 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

ABIOMED, Inc. (NASDAQ: ABMD)

ABMD Technical Analysis 4
As on 23rd Feb 2017 ABMD Share Price closed @ 116.89 and we RECOMMEND Buy for LONG-TERM with Stoploss of 111.11 & Strong Buy for SHORT-TERM with Stoploss of 112.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABMD Target for February
1st Target up-side 113.23
2nd Target up-side 118.03
3rd Target up-side 122.84
1st Target down-side 99.51
2nd Target down-side 94.71
3rd Target down-side 89.9
ABMD Other Details
Segment EQ
Market Capital 527299872.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.abiomed.com
ABMD Address
ABMD
22 Cherry Hill Drive
Danvers, MA 01923
United States
Phone: 978-646-1400
Fax: 978-777-8411
Interactive Technical Analysis Chart ABIOMED, Inc. ( ABMD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ABIOMED, Inc.
ABMD Business Profile
ABIOMED, Inc., incorporated on June 4, 1987, is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In September 2012, the Company announced that its Impella CP product received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for partial circulatory support for up to six hours. In November 2012, the Company announced that the Impella RP received Investigational Device Exemption, or IDE, approval from the FDA for use in RECOVER RIGHT, a pivotal clinical study in the U.S. In December 2012, as part of the FDA's 515 Program Initiative, an FDA panel voted to recommend continuation of Class III status for temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes the Company's Impella products. The Company Headquarters is at 22 Cherry Hill Drive, Danvers, Massachusetts 01923.